Literature DB >> 28412032

Upregulation of MiR-369-3p suppresses cell migration and proliferation by targeting SOX4 in Hirschsprung's disease.

Weikang Pan1, Hui Yu1, Baijun Zheng1, Ya Gao2, Peng Li1, Qiang Huang1, Chong Xie1, Xin Ge1.   

Abstract

BACKGROUND: Hirschsprung disease (HSCR) is a congenital digestive disease in the new born. miR-369-3p has been reported to be involved in many human diseases. However, the relationship between miR-369-3p and HSCR remains largely unknown.
METHODS: In this study, qRT-PCR was used to detect the relative expression of miR-369-3p in 60 HSCR bowel tissue samples and 47 matched controls. Bioinformatic analysis and dual-luciferase reporter assay were performed to evaluate the target for miR-369-3p. Cell Counting Kit-8 (CCK-8) assay, Transwell assay, wound healing assay and flow cytometry were employed to investigate the biological function of miR-369-3p in human SH-SY5Y and 293T cell lines.
RESULTS: We found that ganglion cell numbers were remarkably reduced while miR-369-3p was significantly upregulated in HSCR tissues compared to that in adjacent normal tissues (P<0.01). Dual-luciferase reporter assay showed that the 3'-UTR of SOX4 was a direct target to miR-369-3p. Moreover, an increased level of miR-369-3p was inversely correlated with decreased levels of SOX4 mRNA and protein (P<0.05, respectively). Dysregulation of miR-369-3p and SOX4 significantly suppressed cell proliferation and migration in SH-SY5Y and 293T cell lines in vitro (P<0.05, respectively).
CONCLUSION: Our study demonstrates that aberrant expression of miR-369-3p might play a crucial role in the development HSCR by regulating SOX4 expression, which may infer that it is an effective diagnostic target in the pathogenesis of HSCR, but investigation is still needed to explore the underlying mechanism.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital diseases; Gastroenterology; Hirschsprung disease; Neural crest cell; miRNAs

Mesh:

Substances:

Year:  2017        PMID: 28412032     DOI: 10.1016/j.jpedsurg.2017.04.002

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  8 in total

1.  miR-100 rs1834306 A>G Increases the Risk of Hirschsprung Disease in Southern Chinese Children.

Authors:  Yun Zhu; Ao Lin; Yi Zheng; Xiaoli Xie; Qiuming He; Wei Zhong
Journal:  Pharmgenomics Pers Med       Date:  2020-08-10

Review 2.  Peptides as epigenetic modulators: therapeutic implications.

Authors:  Yorick Janssens; Evelien Wynendaele; Wim Vanden Berghe; Bart De Spiegeleer
Journal:  Clin Epigenetics       Date:  2019-07-12       Impact factor: 6.551

3.  MiR-369-3p participates in endometrioid adenocarcinoma via the regulation of autophagy.

Authors:  Ping Liu; Chengbin Ma; Qiongwei Wu; Wenying Zhang; Cao Wang; Li Yuan; Xiaowei Xi
Journal:  Cancer Cell Int       Date:  2019-07-11       Impact factor: 5.722

4.  An Antisense Oligonucleotide Drug Targeting miR-21 Induces H1650 Apoptosis and Caspase Activation.

Authors:  Jian-Hua Ge; Jing-Wei Zhu; Hai-Yan Fu; Wen-Bo Shi; Chun-Lai Zhang
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec

5.  miR-369 inhibits Liver Cancer progression by targeting ZEB1 pathway and predicts the prognosis of HCC patients.

Authors:  Yuwei Dong; Fuxia Li; Junjun Wang; Jiangfeng Hu; Zhenghong Li; Yubei Gu; Yun Feng
Journal:  J Cancer       Date:  2021-03-19       Impact factor: 4.207

6.  Knockdown of long non‑coding RNA DLEU2 suppresses idiopathic pulmonary fibrosis by regulating the microRNA‑369‑3p/TRIM2 axis.

Authors:  Hengzhong Yi; Danlin Luo; Yangbao Xiao; Di Jiang
Journal:  Int J Mol Med       Date:  2021-03-24       Impact factor: 4.101

7.  MicroRNA Expression Analysis of Mice Retinas with Oxygen-Induced Retinopathy by RNA Sequencing.

Authors:  Xiuping Chen; Xianglian Li; Yan Liu; Yuanzhi Yuan; Yifan Feng; Jing Wang; Min Li; Dongmei Gao; Fei Yuan
Journal:  J Ophthalmol       Date:  2022-03-03       Impact factor: 1.909

8.  Loss of miR-369 Promotes Tau Phosphorylation by Targeting the Fyn and Serine/Threonine-Protein Kinase 2 Signaling Pathways in Alzheimer's Disease Mice.

Authors:  Xiaoguang Yao; Xiaohui Xian; Mingxing Fang; Shujuan Fan; Wenbin Li
Journal:  Front Aging Neurosci       Date:  2020-01-31       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.